## Abstract Ageβadjusted incidence rates of breast cancer vary more than 10βfold worldwide, with the highest rates reported in North America and Europe. The highest breast cancer incidence rates in Southeast Asia have been reported for the Manila Cancer Registry in the Philippines, with an ageβstan
β¦ LIBER β¦
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
β Scribed by Talia Donenberg; John Lunn; DuVaughn Curling; Theodore Turnquest; Elisa Krill-Jackson; Robert Royer; Steven A. Narod; Judith Hurley
- Book ID
- 106378991
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 186 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BRCA1 and BRCA2 mutations among breast c
β
Maria Lourdes De Leon Matsuda; Alexander Liede; Elaine Kwan; Cynthia A. Mapua; E
π
Article
π
2002
π
John Wiley and Sons
π
French
β 183 KB
π 2 views
Prevalence of BRCA1 and BRCA2 mutations
β
Magda C. B. Gomes; Mauricio M. Costa; Radovan Borojevic; Alvaro N. A. Monteiro;
π
Article
π
2006
π
Springer US
π
English
β 112 KB
High prevalence of BRCA1 and BRCA2 mutat
β
James D. Fackenthal; Jing Zhang; Bifeng Zhang; Yonglan Zheng; Fitsum Hagos; Devi
π
Article
π
2012
π
John Wiley and Sons
π
French
β 797 KB
Prevalence of BRCA1 and BRCA2 mutations
β
Abugattas, J.; Llacuachaqui, M.; Allende, Y. Sullcahuaman; VelΓ‘squez, A. Arias;
π
Article
π
2014
π
John Wiley and Sons
π
English
β 266 KB
BRCA1 and BRCA2 mutations among familial
β
GA GutiΓ©rrez Espeleta; M Llacuachaqui; L GarcΓa-JimΓ©nez; M Aguilar Herrera; K Lo
π
Article
π
2011
π
John Wiley and Sons
π
English
β 572 KB
Prevalence of founder BRCA1 and BRCA2 mu
β
Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay;
π
Article
π
2000
π
John Wiley and Sons
π
French
β 55 KB
π 2 views
We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation